Ellanse Composition – What Is the Dermal Filler Made Of?

Did you know that most dermal fillers contain and utilize hyaluronic acid, a powerful substance naturally present in the skin? These fillers are famous for their ability to reduce wrinkles and add volume. However, the composition of dermal fillers can vary significantly, affecting their longevity and effectiveness.

Ellanse stands out in the market due to its unique composition. Unlike traditional fillers, Ellanse provides immediate volume and stimulates the body’s collagen production over time. This dual-action approach offers longer-lasting results, making it a preferred choice for many seeking non-surgical facial enhancements.

In this article, we will delve into Ellanse’s composition. We’ll explore what makes this dermal filler unique, how it works, and why it might be the right choice for your aesthetic needs.

Key Takeaways

• Ellanse is a dermal filler with a unique composition that sets it apart from other fillers like Sculptra and Radiesse.
• Ellanse’s key ingredients are polycaprolactone (PCL) microspheres and a biodegradable gel carrier, stimulating collagen production and providing long-lasting results.
• Clinical studies and expert opinions support the safety, efficacy, and patient satisfaction with Ellanse, making it a popular choice for aesthetic treatments.

About: Doctor Medica is your trusted supplier of top-quality dermal fillers, viscosupplements, and more for your medical practice. We offer genuine products from leading brands at the lowest prices in the market. If you’re looking to buy Ellanse for your practice, contact the Doctor Medica today.

What is Ellanse Made Of?

Ellanse is composed of polycaprolactone (PCL) microspheres, a key component that sets it apart from other dermal fillers. PCL is a biodegradable, biocompatible polymer widely used in medical applications, including sutures and drug delivery systems. These microspheres are designed to be smooth and uniform, facilitating a controlled and predictable response once injected into the skin. 

The primary function of PCL microspheres in Ellanse is to stimulate the body’s natural collagen production. Over time, as the PCL microspheres gradually degrade, they leave behind a scaffold of new collagen fibers, providing long-lasting volume and structural support to the treated areas.

In addition to PCL microspheres, Ellanse includes a biodegradable gel carrier. This carrier gel is composed of carboxymethylcellulose (CMC), a substance that helps distribute the microspheres evenly within the tissue. The gel carrier ensures the smooth injection and immediate volumizing effect upon administration.

While the PCL microspheres work on a longer-term basis to stimulate collagen, the CMC gel provides instant lift and support, enhancing the initial aesthetic results. The gel is fully biodegradable and is naturally absorbed by the body over time, contributing to the overall biocompatibility and safety of the treatment.

Together, the PCL microspheres and the biodegradable gel carrier create a dual-action dermal filler that not only provides immediate volumizing effects but also promotes long-term skin rejuvenation by enhancing collagen production. This combination makes Ellanse an effective and long-lasting option for addressing various signs of aging and improving overall skin quality.

The Role of Polycaprolactone (PCL) Microspheres

Polycaprolactone (PCL) microspheres are crucial in Ellanse’s effectiveness by stimulating collagen production. When injected into the skin, these biocompatible and biodegradable microspheres act as a scaffold for new collagen synthesis. The body’s natural response to the presence of PCL microspheres is to produce collagen around them, gradually enhancing the skin’s structure. This leads to improved firmness, elasticity, and a more youthful appearance over time.

Longevity of Results

One of the standout features of Ellanse is the longevity of its results, which can last significantly longer than many other dermal fillers. The PCL microspheres in Ellanse degrade slowly, typically over 1 to 4 years, depending on the specific product used.

As the microspheres dissolve, they continue to stimulate collagen production, ensuring that the skin remains rejuvenated and volumized for an extended period. This long-lasting effect reduces the need for frequent touch-up treatments, making Ellanse a cost-effective and convenient option for long-term facial rejuvenation.

Combining immediate volumizing effects from the gel carrier and sustained collagen production stimulated by PCL microspheres provides a dual benefit, ensuring immediate and enduring improvements in skin texture and volume. This unique mechanism of action distinguishes Ellanse as a versatile and effective dermal filler for those seeking long-lasting aesthetic enhancements.

Benefits of the Biodegradable Gel Carrier

• Controlled and Sustained Release: The biodegradable gel carrier in Ellanse ensures a controlled, sustained release of PCL microspheres. This promotes continuous collagen production, providing immediate volumizing effects and long-term skin rejuvenation.
• Biocompatibility and Safety: The gel carrier, made from carboxymethyl cellulose (CMC), is biocompatible and safe. It minimizes adverse reactions and is naturally absorbed by the body, reducing long-term complications while ensuring effective facial rejuvenation. Furthermore, Ellanse received its CE Marking in 2009, proving it meets high safety standards. 

Clinical Studies and Expert Opinions on Ellanse

Clinical studies and rigorous clinical trials have shown that Ellanse is both safe and effective for facial rejuvenation. Its unique composition of PCL microspheres and biodegradable gel carrier ensures long-lasting results with minimal side effects. Experts highlight its ability to stimulate collagen production, leading to natural-looking improvements that can last up to four years.

Moreover, this filler has garnered positive reviews, with patients saying they are satisfied with Ellanse’s smoothing of facial lines and volume restoration. Although it has not yet received FDA approval in the United States, it is approved for use in certain countries. Proper Ellanse aftercare is essential for maintaining these results and ensuring patient safety.

Conclusion

Ellanse stands out due to its unique PCL microspheres and biodegradable gel mix. This combo works wonders by filling in the skin and kicking off collagen production for long-lasting beauty effects.

Unlike other fillers, Ellanse harnesses your body’s natural powers to improve skin from within. Safe, effective, and long-lasting, it offers a promising option for those looking to confidently turn back the clock on aging.

Indeed, this dermal filler brings science and beauty together in an impressive way!

FAQs

1. What is Ellanse made of?

Ellanse, a popular dermal filler, is composed of unique materials designed to rejuvenate your skin.

2. How does the composition of Ellanse differ from other fillers?

Unlike most fillers that use hyaluronic acid or collagen, Ellanse uses a different material. It’s this unique composition that sets it apart.

3. Is the material used in Ellanse safe for my skin?

Absolutely! The components used in Ellanse are biocompatible and bioresorbable, meaning they work well with your body and naturally dissolve over time.

4. Can I expect long-lasting results with Ellanse due to its unique composition?

Thanks to its unique ingredients, results from an Ellanse treatment can last up to four years, which is much longer than many other dermal fillers on the market.

References

American Society of Plastic Surgeons. (2023). Dermal fillers. American Society of Plastic Surgeons. https://www.plasticsurgery.org/cosmetic-procedures/dermal-fillers

Sinclair Pharma. (2022, March 28). Ellanse: An expert’s guide. https://sinclairprodstorage.blob.core.windows.net/media/z4bdzreh/ellans%C3%A9-an-experts-guide-digital-singles-2-00-stc-28mar22singles-1-27-1.pdf

Chen, Q., & Wang, Y. (2024). Ellanse: Advanced Technology and Advantageous Selection of New Collagen Stimulating Agents for Face Rejuvenation. Aesthetic plastic surgery, 48(10), 1977–1984. https://doi.org/10.1007/s00266-023-03761-w